Clinical Drug Experience Knowledgebase

Aged (Phase 1/Phase 2)

Biliary Tract Neoplasms (Phase 1/Phase 2)

Bone Marrow Cells (Phase 1)

Breast Neoplasms (Phase 1)

Carcinoma, Hepatocellular (Phase 1/Phase 2)

Carcinoma, Merkel Cell (Phase 1)

Carcinoma, Mucoepidermoid (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 1/Phase 2)

Carcinoma, Renal Cell (Phase 1)

Carcinoma, Squamous Cell (Phase 1)

Carcinoma, Transitional Cell (Phase 1)

Colorectal Neoplasms (Phase 1)

COVID-19 (Phase 2)

Fallopian Tube Neoplasms (Phase 2)

Glioblastoma (Phase 1)

Gliosarcoma (Phase 1)

Hamartoma (Phase 2)

Head and Neck Neoplasms (Phase 1)

Hematologic Neoplasms (Early Phase 1)

Hodgkin Disease (Phase 2)

Leukemia (Phase 1/Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Lymphoma (Phase 1/Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Melanoma (Phase 1)

Mesothelioma (Phase 1)

Microsatellite Instability (Phase 1)

Myelodysplastic Syndromes (Phase 2)

Neoplasm Metastasis (Phase 1)

Neoplasms (Phase 2)

Neuroblastoma (Phase 2)

Osteosarcoma (Phase 2)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 1)

Rhabdomyosarcoma (Phase 2)

Sarcoma, Ewing (Phase 2)

Small Cell Lung Carcinoma (Phase 1)

Stomach Neoplasms (Phase 1)

Uterine Cervical Neoplasms (Phase 1)